A large population-based study found that statin use was significantly associated with a reduced risk of SAH. Research suggested potential clinical benefit to statins in this setting, particularly in ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Buscot and colleagues aimed to examine the optimal onset ...

The effect of a liberal red-cell transfusion strategy as compared with a restrictive strategy in patients during the critical care period after an aneurysmal subarachnoid hemorrhage is unclear. We ...

This Journal feature begins with a case vignette highlighting a common clinical problem. Evidence supporting various strategies is then presented, followed by a review of formal guidelines, when they ...

Aneurysmal subarachnoid hemorrhage-related hydrocephalus (aSAH-H) is a clinical syndrome that leads to excessive accumulation of cerebrospinal fluid (CSF) and ventricle enlargement in the brain.

Rates of one type of stroke called subarachnoid hemorrhage have increased in older people and men in recent years, and such strokes occur in Black people at a disproportionately higher rate compared ...

Please provide your email address to receive an email when new articles are posted on . The FDA has granted orphan drug designation to NeurOp Inc. for an investigational candidate for treating ...

A Prescription Drug User Fee Act target date of April 23, 2026 has been set for the application. The Food and Drug Administration (FDA) has accepted for review the New Drug Application (NDA) for ...

ATLANTA--(BUSINESS WIRE)--NeurOp, Inc., a clinical-stage biotechnology company focused on neurological and psychiatric disorders, today announced that the U.S. Food and Drug Administration (FDA) has ...